CERTIFIED MEDICATION ASSISTED TREATMENT (MAT) ADVOCATE (CMA)-1

The Basic Advocacy Training Session

The training for certification includes a variety of topics to give advocates a well-grounded understanding of MAT, research, regulations and laws that protect MAT patients and programs.

  1. Medication Assisted Treatment  Basic clinical information about methadone and buprenorphine treatment.

  2. Regulations and Accreditation The federal regulations will be explained:  What they are and how they relate to the state regulations? Accreditation and what an accreditation survey is, how it is done, and how advocates can be involved.

  3. The Basics of Advocacy The different kinds of advocacy from “Hands On” Individual Advocacy (handling a grievavce), Networking, Systems Advocacy, Working with Policy Makers and Politicians.

  4. Stigma and Prejudice Patients themselves are often the greatest spreaders of stigma through ignorance and myths. Stigma will only end when society is educated about the effectiveness and benefits of MAT from the bottom up. We need to start with patients who can become ambassadors for MAT but this will be most effective with the support of policy makers and regulating agencies. The Media also spreads misinformation and stigma about MAT. Advocates need to have basic skills to work with the Media and write an Editorial, Letter to the Editor LTE and a Press Release.

  5. Advocate Certification What is certification and how it will professionalize those committed to MAT advocacy.  The Advocates Code of Ethics, the Goals of MAT Advocacy, and Advocate Certification.

Similar Posts

  • Events

    Admin 11/01/2022

    AMTA Conference 2000 American Methadone Treatment Association April 9-12, 2000 San Francisco Preconference Meeting How Can We Develop and Strengthen Patient Advocacy Groups? Day: Sunday Date: April 9, 2000 Time: 1 – 5 PM Moderator: John Finger, TexNAMA Presenters: Joycelyn Woods, NAMA Diane Fleury-Seaman, MALTA Fred Christie, AFIRM James DePasquale, Membership Director/Chapter Coordinator of NAMA…

  • Lindesmith Center Seminar Schedule

    Admin 08/05/2022

    The Lindesmith Center’s SPECIAL DRUG POLICY SEMINAR SERIES Summer and Fall 1996 DRUG TREATMENT RECONSIDERED: HARM REDUCTION PERSPECTIVES The Lindesmith Center is presenting a special seminar series on the relationship between drug treatment and harm reduction. Harm reduction services focus on reducing the negative consequences of drug use among those unwilling or unable to abstain….

  • At ATTOD

    Admin 02/19/2022

    Methadone Advocate Training   Want to know what a Methadone Conference is like? Check out our report on the NAMA website methadone.org                         FIRST EVER METHADONE (MAT) ADVOCATE TRAINING AND CERTIFICATION AT THE 2003 AATOD CONFERENCE IN Washington, DC SATURDAY APRIL 12, 2003 Information about the first ever CMA Training at AATOD on April 12,…

  • Category: Press Release

    Admin 07/14/2022

    Herman Joseph, PhD 1931 – 2019 May 28, 2019 May 6, 2019 Dr. Joseph was one of the important influences on addiction and criminal justice during the latter 20th and early 21st century.  For more than 50 years he has worked as a social research scientist in the interrelated fields of addiction, treatment, criminal justice,…

  • NAMA Policy Statement: Blind Dosing and Patient Dignity

    Admin 06/10/2023

    Methadone maintenance treatment has been the most effective treatment for addiction to heroin resulting the cessation of heroin use and criminal behavior. Prior to the development of methadone maintenance treatment over 28 years ago narcotic addiction was considered incurable and a behavioral disorder under the control of law enforcement. Drs. Dole and Nyswander brought the…